Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
«
»
6 Hits
Search Condition : Filter (MeSH = Aniline Compounds)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
PC-9(RCB4455)
68844
Design, synthesis and evaluation of the osimertinib analogue (C-005) as potent EGFR inhibitor against NSCLC.
Bioorg Med Chem
2018-12-15
Pubmed
Full text
Human and Animal Cells
PC-9(RCB4455)
61895
Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung Cancer.
J Thorac Oncol
2020-5-1
Pubmed
Full text
Human and Animal Cells
Ba/F3(RCB0805)
59655
Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFR‑mutant Ba/F3 cells.
Oncol Rep
2019-2-1
Pubmed
Full text
Human and Animal Cells
PC-9(RCB4455)
54821
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
Nat Commun
2019-1-16
Pubmed
Full text
Human and Animal Cells
PC-9(RCB4455)
52399
Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors.
Cell Chem Biol
2017-11-16
Pubmed
Full text
DNA material
pENTER-EGFR wild-type (RDB15488)
,
pENTER-EGFR Del19 (RDB15489)
,
pENTER-EGFR T790M/del19 (RDB15490)
,
pENTER-EGFR C797S/del19 (RDB15491)
,
pENTER-EGFR C797S/T790M/del19 (RDB15492)
,
pENTER-EGFR L858R (RDB15493)
,
pENTER-EGFR T790M/L858R (RDB15494)
,
pENTER-EGFR C797S/L858R (RDB15495)
,
pENTER-EGFR C797S/T790M/L858R (RDB15496).
50056
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.
Nat Commun
2017-3-13
Pubmed
Full text